Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785376 · ClinicalTrials.gov registry record · NA
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men
A NA study of PrEP Uptake and HIV Testing, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT06785376: Recruiting NA study of PrEP Uptake and HIV Testing, sponsored by Columbia University.
NCT06785376 is a NA study of PrEP Uptake and HIV Testing that is actively recruiting participants, run by Columbia University. The registered enrollment target is 480 participants, above the 295-participant average among 3 other PrEP Uptake trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06785376, a NA study of PrEP Uptake and HIV Testing, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.
Primary Outcome
did the participant engage in HIV testing in the past 3 months
Conditions Studied
Interventions
- BEHAVIORAL DIY (Do It Yourself)
- BEHAVIORAL TRUST
- BEHAVIORAL SOC
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2024-12-19 |
| Est. Completion | 2028-02-28 |
| Phase | NA |
What NCT06785376 shows while recruiting
NCT06785376 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 295-participant average among 3 other PrEP Uptake trials with a reported enrollment target (63% higher).
The record links to 2 conditions, with PrEP Uptake appearing as the primary indexed condition, and to 3 interventions - of which DIY (Do It Yourself) is the first listed.
NCT06785376 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06785376 about?
NCT06785376 is a clinical study titled "P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men". The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed c...
What is the current status of trial NCT06785376?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2024-12-19. Estimated completion is 2028-02-28.
What conditions does trial NCT06785376 study?
This clinical trial studies the following conditions: PrEP Uptake, HIV Testing.
What interventions are being tested in trial NCT06785376?
The interventions under investigation include: DIY (Do It Yourself) (BEHAVIORAL), TRUST (BEHAVIORAL), SOC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06785376?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785376 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PrEP Uptake
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI